Frazier Life Sciences XI, L.P.
10% Owner
FundBuying only
- 2026
- Aug 6, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frazier Life Sciences XI, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- GOLDMAN SACHS GROUP INC - $27.32M in ATTO purchases and sales in the last 12 months
- Colin Walsh - $27.32M in ATTO purchases and sales in the last 12 months
- Redmile Group, LLC - $10.20M in ATTO purchases and sales in the last 12 months
- venBio Global Strategic Fund IV, L.P. - $6.50M in ATTO purchases and sales in the last 12 months
- Sanofi - $5.10M in ATTO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Frazier Life Sciences XI, L.P.?
Frazier Life Sciences XI, L.P. is an investment firm, tracked as 10% Owner of Attovia Therapeutics, Inc. (ATTO). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Frazier Life Sciences XI, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Frazier Life Sciences XI, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10.00M) and 0 open-market sales across all tracked filings.
